Cancer Susceptibility and Signaling Pathways in Low-Grade Brain Tumors |
Jewish General Hospital / Bárbara Rivera, PhD |
Young Investigator Grants |
2017 |
Quebec |
Uncovering the signaling mechanisms allowing medulloblastoma progenitor cells to orchestrate tumor relapse |
Medical University of South Carolina / Jezabel Rodriguez Blanco, PhD |
'A' Award Grants |
2023 |
South Carolina |
Evaluation of the Literacy Demand and Racial/Ethnic Influences for Self-Reported Symptomatic Adverse Events during Childhood Cancer Therapy |
Palmetto Health / Janice Withycombe, PhD |
Nurse Researcher Grants |
2013 |
South Carolina |
CD36-Sphingosine 1-Phosphate Axis in Osteosarcoma Progression |
Medical University of South Carolina / Meenal Mehrotra, MD/PhD |
Innovation Grants |
2019 |
South Carolina |
Enhancing Coping and Communication in Children with Cancer and Their Parents: A Novel Internet-Based Intervention |
Vanderbilt University Medical Center / Bruce Compas, PhD |
Psychosocial Grants |
2016 |
Tennessee |
Targeting wnt in synovial sarcoma models.
|
Vanderbilt University Medical Center / Josiane Eid |
Innovation Grants |
2009 |
Tennessee |
CD47-blocking Oncolytic Vaccinia Viruses as Biotherapeutics for Pediatric Solid Tumors |
St. Jude Children’s Research Hospital / Stephen Gottschalk, MD & Nino Rainusso, MD |
Innovation Grants |
2016 |
Tennessee |
Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS |
St. Jude Children’s Research Hospital / Dirk Loeffler, PhD |
RUNX1 Early Career Investigator Grants |
2023 |
Tennessee |
ECM-targeted CAR T-cell therapy for high-grade glioma |
St. Jude Children’s Research Hospital / Jessica Wagner, PhD |
Young Investigator Grants |
2019 |
Tennessee |
NUDT15 Polymorphisms and Individualization of Thiopurine Therapy in Children with Acute Lymphoblastic Leukemia |
St. Jude Children’s Research Hospital / Takaya Moriyama, MD/PhD |
Young Investigator Grants |
2018 |
Tennessee |